✦ LIBER ✦
Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer
✍ Scribed by Goldkorn, A.; Ely, B.; Quinn, D. I.; Tangen, C. M.; Fink, L. M.; Xu, T.; Twardowski, P.; Van Veldhuizen, P. J.; Agarwal, N.; Carducci, M. A.; Monk, J. P.; Datar, R. H.; Garzotto, M.; Mack, P. C.; Lara, P.; Higano, C. S.; Hussain, M.; Thompson, I. M.; Cote, R. J.; Vogelzang, N. J.
- Book ID
- 127154250
- Publisher
- American Society of Clinical Oncology
- Year
- 2014
- Tongue
- English
- Weight
- 180 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.